Skip to content
Congress·In Committee·about 1 year ago

Congress Proposes Expanding Medicare Coverage for New Lung Cancer Screening Tests

Legislative Progress

Filed
Review
House
Senate
President

Impact Analysis

Scores: 1 = low, 5 = highSentiment: -5 to +5 (net benefit)

Key Points

  • This bill gives Medicare the power to cover new types of lung cancer screening tests. Currently, Medicare is limited in which tests it can pay for, but this change would allow it to include newer, more advanced options as they are developed.
  • Any new test would have to be approved by the Food and Drug Administration (FDA) before Medicare covers it. This ensures that the screenings are safe and actually work before they are offered to patients.
  • The main goal is to help doctors find lung cancer earlier, which makes it much easier to treat. By covering more types of tests, the government hopes to reach more people and save lives through early detection.
  • Government health officials will work with medical experts to decide who should get these tests and how often. They will also set the rules for how much the government will pay doctors and labs for performing these screenings.
Healthcare

Milestones

2 milestones2 actions
Feb 18, 2025House

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Feb 18, 2025

Introduced in House

Source Information

Document Type

Congressional Bill

Official Title

Lung Cancer Screening and Prevention Act of 2025

Bill NumberHR 1406
Congress119th Congress
ChamberHouse of Representatives
Latest ActionReferred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Sponsor

Cosponsors

(8)
D: 5R: 3

Analysis generated by AI. While we strive for accuracy, this should not be considered legal or professional advice. Always verify information with official government sources.